Join us Sept. 14-18 in Miami to connect with top publishing leaders
Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
S4 and Monks are trying to get ahead of rising AI token costs
Monks is considered a leader in AI marketing services, but “exploding” use of AI tokens poses difficult questions for execs focused on keeping costs down.
OpenAI is coming for SMB advertisers
The company is going after smaller advertisers. Its job listings prove it.
Zoom relies on creators to boost AI search results
As AI changes how brands are discovered, Zoom is leaning on creators and journalists to shape its reputation.